tiprankstipranks
Crescent Biopharma (CBIO)
NASDAQ:CBIO
CBIO
Crescent Biopharma
RESEARCH TOOLSreports
Want to see CBIO full AI Analyst Report?

Crescent Biopharma (CBIO) Revenue

1,026 Followers
StatisticsMarket CapRevenue

Crescent Biopharma Revenue

Crescent Biopharma had a revenue of 1.04M in the quarter ending Mar 31, 2026, with -90.42%. This bring the company's revenue in the last twelve months to 11.88M, Decreased 9.58%. In the fiscal year ending Dec 31, 2025, Crescent Biopharma had annual revenue of 10.84M with Infinity% growth.
Revenue (ttm)
11.88M
Revenue Growth
―
P/S Ratio
50.78
Revenue/Employee
$264,488
Employees
41
Market Cap
$550.61M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
10.84M―+∞%
Dec 31, 2024
―-10.00K-100.00%
Dec 31, 2023
10.00K-65.00K-86.67%
Dec 31, 2022
75.00K-1.08M-93.53%
Dec 31, 2021
1.16M-9.00M-88.59%
Dec 31, 2020
10.16M―+∞%
Dec 31, 2019
―――
Dec 31, 2018
―――
Dec 31, 2017
―――